ROSEN, LEADING INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA
Portfolio Pulse from
Rosen Law Firm is urging investors of Intellia Therapeutics, Inc. (NASDAQ:NTLA) who purchased securities between July 30, 2024, and January 8, 2025, to secure counsel before the April 14, 2025, lead plaintiff deadline in a securities class action.
March 19, 2025 | 10:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rosen Law Firm is encouraging Intellia Therapeutics investors to join a securities class action if they purchased shares between July 30, 2024, and January 8, 2025. The deadline for lead plaintiff is April 14, 2025.
The announcement of a securities class action can negatively impact investor sentiment and potentially lead to a short-term decline in stock price as investors react to the legal risks and uncertainties.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100